glucuronic acid has been researched along with Ischemia in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 10 (90.91) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, EM; Doherty, EG; Doherty, EJ; Grossman, PM; Hao, Y; Martinick, KD; Mooney, DJ; Silva, EA; Stafford, AG; Vermillion, SA; Wang, L | 1 |
Cho, JY; Choi, YJ; Hwang, NS; Kang, BJ; Kim, BS; Kim, J; Kim, PH; Kwon, SM; Yim, HG | 1 |
Anderson, EM; Kwee, BJ; Lewin, SA; Mehta, M; Mooney, DJ; Raimondo, T | 1 |
Cohen, S; Fredo, R; Freeman, I; Ruvinov, E | 1 |
DiPietro, LA; Jeong, JH; Ko, E; Kong, H; Lee, MK; Schmidt, J | 1 |
Baker, AB; Das, S; Dunn, AK; Lam, B; Martin, PE; Monteforte, AJ; Mukhopadhyay, S; Wright, CS | 1 |
Fritton, JC; Grossman, PM; Mooney, DJ; Rajagopalan, S; Schaffler, MB; Silva, EA; Sun, Q; Wang, A | 1 |
Cohen, S; Leor, J; Ruvinov, E | 1 |
Cao, X; Griffith, M; Kuraitis, D; McEwan, K; McKee, D; Ruel, M; Sofrenovic, T; Suuronen, EJ; Zhang, J; Zhang, P | 1 |
Flores, CA; Joseph, G; Landázuri, N; Levit, RD; Ortega-Legaspi, JM; Safley, SA; Sambanis, A; Taylor, WR; Weber, CJ; Weiss, D | 1 |
Bertram, JP; Jay, SM; Pober, JS; Saltzman, WM; Shepherd, BR | 1 |
11 other study(ies) available for glucuronic acid and Ischemia
Article | Year |
---|---|
VEGF and IGF Delivered from Alginate Hydrogels Promote Stable Perfusion Recovery in Ischemic Hind Limbs of Aged Mice and Young Rabbits.
Topics: Age Factors; Alginates; Angiogenesis Inducing Agents; Angiography, Digital Subtraction; Animals; Disease Models, Animal; Drug Carriers; Drug Compounding; Female; Glucuronic Acid; Hexuronic Acids; Hindlimb; Hydrogels; Insulin-Like Growth Factor I; Ischemia; Mice, Inbred C57BL; Muscle, Skeletal; Neovascularization, Physiologic; Rabbits; Recovery of Function; Regional Blood Flow; Time Factors; Vascular Endothelial Growth Factor A | 2017 |
Injectable multifunctional microgel encapsulating outgrowth endothelial cells and growth factors for enhanced neovascularization.
Topics: Alginates; Animals; Aorta; Cell- and Tissue-Based Therapy; Cells, Cultured; Endothelial Cells; Extremities; Female; Fluorescein-5-isothiocyanate; Gels; Glucuronic Acid; HEK293 Cells; Hepatocyte Growth Factor; Hexuronic Acids; Human Umbilical Vein Endothelial Cells; Humans; Injections; Ischemia; Mice, Inbred BALB C; Neovascularization, Physiologic; Oligopeptides; Rats, Sprague-Dawley; Regional Blood Flow; Serum Albumin, Bovine; Vascular Endothelial Growth Factor A | 2014 |
Local delivery of VEGF and SDF enhances endothelial progenitor cell recruitment and resultant recovery from ischemia.
Topics: Alginates; Animals; Blood Vessels; Cell Adhesion; Cell Movement; Chemokine CXCL12; Drug Delivery Systems; Endothelial Progenitor Cells; Glucuronic Acid; Hexuronic Acids; Hindlimb; Humans; Hydrogels; Inflammation; Ischemia; Mice, Inbred C57BL; Neovascularization, Physiologic; Reperfusion; Vascular Endothelial Growth Factor A | 2015 |
Spontaneous Coassembly of Biologically Active Nanoparticles via Affinity Binding of Heparin-Binding Proteins to Alginate-Sulfate.
Topics: Alginates; Animals; Biocompatible Materials; Disease Models, Animal; Drug Carriers; Glucuronic Acid; Heparin; Hexuronic Acids; Hindlimb; Ischemia; Myocardial Infarction; Nanoparticles; Protein Binding; Regenerative Medicine; Sulfates | 2016 |
Alginate Sulfates Mitigate Binding Kinetics of Proangiogenic Growth Factors with Receptors toward Revascularization.
Topics: Alginates; Animals; Capillaries; Cells, Cultured; Glucuronic Acid; Hexuronic Acids; Hindlimb; Human Umbilical Vein Endothelial Cells; Humans; Ischemia; Kinetics; Mice; Mice, Inbred C57BL; Mice, SCID; Neovascularization, Pathologic; Sulfates; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2016 |
Glypican-1 nanoliposomes for potentiating growth factor activity in therapeutic angiogenesis.
Topics: Alginates; Animals; Blood Vessels; Cell Movement; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Delivery Systems; Endosomes; Fibroblast Growth Factor 2; Glucuronic Acid; Glypicans; HEK293 Cells; HeLa Cells; Hexuronic Acids; Hindlimb; Human Umbilical Vein Endothelial Cells; Humans; Ischemia; Kinetics; Liposomes; Mice, Obese; Nanoparticles; Neovascularization, Physiologic; Proto-Oncogene Proteins c-akt; Signal Transduction; Skin; Vascular Endothelial Growth Factor A | 2016 |
Sustained release of multiple growth factors from injectable polymeric system as a novel therapeutic approach towards angiogenesis.
Topics: Alginates; Angiogenesis Inhibitors; Animals; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; Hindlimb; Intercellular Signaling Peptides and Proteins; Ischemia; Male; Mice; Mice, Knockout; Neovascularization, Physiologic; Polyesters; Polymers; Random Allocation | 2010 |
The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model.
Topics: Alginates; Animals; Biocompatible Materials; Drug Carriers; Female; Glucuronic Acid; Hepatocyte Growth Factor; Hexuronic Acids; Hindlimb; Hydrogel, Polyethylene Glycol Dimethacrylate; Injections; Ischemia; Materials Testing; Mice; Mice, Inbred BALB C; Neovascularization, Physiologic; Random Allocation; Rats; Rats, Sprague-Dawley | 2010 |
Controlled release of stromal cell-derived factor-1 for enhanced progenitor response in ischemia.
Topics: Alginates; Angiogenesis Inducing Agents; Animals; Cells, Cultured; Chemistry, Pharmaceutical; Chemokine CXCL12; Chemotaxis; Collagen Type I; Delayed-Action Preparations; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Glucuronic Acid; Hexuronic Acids; Hindlimb; Humans; Injections, Intramuscular; Ischemia; Mice; Mice, Inbred C57BL; Microspheres; Muscle, Skeletal; Neovascularization, Physiologic; Particle Size; Rheology; Stem Cells; Technology, Pharmaceutical | 2011 |
Alginate microencapsulation of human mesenchymal stem cells as a strategy to enhance paracrine-mediated vascular recovery after hindlimb ischaemia.
Topics: Alginates; Animals; Capsules; Cell Survival; Cells, Immobilized; Glucuronic Acid; Hexuronic Acids; Hindlimb; Humans; Ischemia; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice, Nude; Neovascularization, Physiologic; Paracrine Communication; Permeability; Wound Healing | 2016 |
Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation.
Topics: Alginates; Animals; Cattle; Cell Survival; Cells, Cultured; Collagen; Drug Delivery Systems; Endothelial Cells; Fibronectins; Gels; Genes, bcl-2; Glucuronic Acid; Hexuronic Acids; Hindlimb; Humans; Ischemia; Lactic Acid; Mice; Mice, Inbred C57BL; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Serum Albumin, Bovine; Tissue Engineering; Transduction, Genetic; Vascular Endothelial Growth Factor A | 2008 |